In 2021 and 2022, COVID-19 drug Veklury (remdesivir) was the No. 1 pharmaceutical expense for the nation’s hospitals. Most medicines on the list saw modest changes from the prior year except for TNKase (tenecteplase), a cardiovascular therapy that cost hospitals 87.9% more in 2023.
The research calculated healthcare drug expenditure among three factors: a drug’s list price, newly approved drugs and utilization.
The top 25 drugs ranked by nonfederal hospital expenditure in 2023:
Pembrolizumab — $1.4 billion (4.4% change from 2022)
Immune globulin — $1 billion (-5.1% change)
Remdesivir — $727,409,000 (-45% change)
Bictegravir/emtricitabine/tenofovir/alafenamide — $643,390,000 (18.9% change)
Sugammadex — $636,441,000 (23.9% change)
Pneumococcal vaccine conjugate — $585,635,000 (29.5% change)
Daratumumab/hyaluronidase — $584,128,000 (17.4% change)
Nivolumab — $551,518,000 (-6.4% change)
Inactivated influenza virus — $541,415,000 (-10% change)
Natalizumab — $503,380,000 (-12.8% change)
Ocrelizumab — $499,917,000 (-0.2% change)
Rituximab — $483,858,000 (-12.9% change)
Sodium intravenous solutions — $483,290,000 (8.2% change)
Antithymocyte immunoglobulin — $481,304,000 (6.5% change)
Alteplase — $475,445,000 (-24.2% change)
Denosumab — $430,814,000 (-0.1% change)
Iohexol — $358,330,000 (14.5% change)
Factor II/factor VII/ factor IX/factor x/protein C/protein S — $329,253,000 (10.2% change)
Vedolizumab — $312,172,000 (-2.1% change)
Tenecteplase — $311,081,000 (87.9% change)
Bupivacaine — $308,309,000 (-14.2% change)
Albumin — $308,166,000 (-11.3% change)
Iopamidol — $302,470,000 (-2.4% change)
Infliximab — $300,332,000 (-23.6% change)
Pegfilgrastim — $299,326,000 (-22.1% change)
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.